1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > North America Acne Drugs Industry 2016 Market Research Report

North America Acne Drugs Industry 2016 Market Research Report

  • April 2016
  • -
  • QY Research Group
  • -
  • 139 pages

The North America Acne Drugs Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Acne Drugs industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Acne Drugs market analysis is provided for the North America markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on North America major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Acne Drugs industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 148 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


Table Of Contents

North America Acne Drugs Industry 2016 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Acne Drugs
1.2 Classification of Acne Drugs
1.3 Applications of Acne Drugs
1.4 Industry Chain Structure of Acne Drugs
1.5 Industry Overview of Acne Drugs
1.6 Industry Policy Analysis of Acne Drugs
1.7 Industry News Analysis of Acne Drugs

2 Manufacturing Cost Structure Analysis of Acne Drugs
2.1 Bill of Materials (BOM) of Acne Drugs
2.2 BOM Price Analysis of Acne Drugs
2.3 Labor Cost Analysis of Acne Drugs
2.4 Depreciation Cost Analysis of Acne Drugs
2.5 Manufacturing Cost Structure Analysis of Acne Drugs
2.6 Manufacturing Process Analysis of Acne Drugs
2.7 North America Price, Cost and Gross of Acne Drugs 2011-2016

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of North America Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of North America Key Acne Drugs Manufacturers in 2015
3.3 RandD Status and Technology Source of North America Acne Drugs Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of North America Acne Drugs Key Manufacturers in 2015

4 Production Analysis of Acne Drugs by Regions, Type, and Applications
4.1 North America Production of Acne Drugs by Regions 2011-2016
4.2 North America Production of Acne Drugs by Type 2011-2016
4.3 North America Sales of Acne Drugs by Applications 2011-2016
4.4 Price Analysis of North America Acne Drugs Key Manufacturers in 2015
4.5 North America Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Acne Drugs 2011-2016

5 Consumption Volume and Consumption Value Analysis of Acne Drugs by Regions
5.1 North America Consumption Volume of Acne Drugs by Regions 2011-2016
5.2 North America Consumption Value of Acne Drugs by Regions 2011-2016
5.3 North America Consumption Price Analysis of Acne Drugs by Regions 2011-2016

6 Analysis of Acne Drugs Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Acne Drugs 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Acne Drugs 2014-2015
6.3 Sales Overview of Acne Drugs 2011-2016
6.4 Supply, Consumption and Gap of Acne Drugs 2011-2016
6.5 Import, Export and Consumption of Acne Drugs 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Acne Drugs 2011-2016

7 Analysis of Acne Drugs Industry Key Manufacturers
7.1 Pfizer
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Pfizer SWOT Analysis

7.2 Galderma
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Galderma SWOT Analysis

7.3 Stiefel
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Stiefel SWOT Analysis

7.4 Valeant
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Valeant SWOT Analysis

7.5 Bayer HealthCare
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Bayer HealthCare SWOT Analysis

7.6 AndroScience
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 AndroScience SWOT Analysis

7.7 GlaxoSmithKline
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 GlaxoSmithKline SWOT Analysis

7.8 Johnson and Johnson
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Johnson and Johnson SWOT Analysis

7.9 Roche
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Roche SWOT Analysis

7.10 Foamix
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Foamix SWOT Analysis

7.11 Promius Pharma
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 Promius Pharma SWOT Analysis

7.12 Teva
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 Teva SWOT Analysis

7.13 Roche
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.13.4 Roche SWOT Analysis

7.14 Anterios
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.14.4 Anterios SWOT Analysis

7.15 Aqua Pharmaceuticals
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.15.4 Aqua Pharmaceuticals SWOT Analysis

7.16 Astellas
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.16.4 Astellas SWOT Analysis

7.17 BioPharmX
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.17.4 BioPharmX SWOT Analysis

7.18 Celtaxsys
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.18.4 Celtaxsys SWOT Analysis

7.19 Cipher Pharmaceuticals
7.19.1 Company Profile
7.19.2 Product Picture and Specification
7.19.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.19.4 Cipher Pharmaceuticals SWOT Analysis

7.20 COSMO Pharmaceuticals
7.20.1 Company Profile
7.20.2 Product Picture and Specification
7.20.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.20.4 COSMO Pharmaceuticals SWOT Analysis

7.21 Dermira
7.21.1 Company Profile
7.21.2 Product Picture and Specification
7.21.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.21.4 Dermira SWOT Analysis

7.22 Elorac
7.22.1 Company Profile
7.22.2 Product Picture and Specification
7.22.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.22.4 Elorac SWOT Analysis

7.23 Guthy-Renker
7.23.1 Company Profile
7.23.2 Product Picture and Specification
7.23.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.23.4 Guthy-Renker SWOT Analysis

7.24 Helix BioMedix
7.24.1 Company Profile
7.24.2 Product Picture and Specification
7.24.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.24.4 Helix BioMedix SWOT Analysis

7.25 Hygeia Therapeutics
7.25.1 Company Profile
7.25.2 Product Picture and Specification
7.25.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.25.4 Hygeia Therapeutics SWOT Analysis

7.26 Meda
7.26.1 Company Profile
7.26.2 Product Picture and Specification
7.26.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.26.4 Meda SWOT Analysis

7.27 Mylan
7.27.1 Company Profile
7.27.2 Product Picture and Specification
7.27.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.27.4 Mylan SWOT Analysis

7.28 Novan
7.28.1 Company Profile
7.28.2 Product Picture and Specification
7.28.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.28.4 Novan SWOT Analysis

7.29 Oculus Innovative Sciences
7.29.1 Company Profile
7.29.2 Product Picture and Specification
7.29.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.29.4 Oculus Innovative Sciences SWOT Analysis

7.30 Paratek Pharmaceuticals
7.30.1 Company Profile
7.30.2 Product Picture and Specification
7.30.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.30.4 Paratek Pharmaceuticals SWOT Analysis

7.31 Photocure
7.31.1 Company Profile
7.31.2 Product Picture and Specification
7.31.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.31.4 Photocure SWOT Analysis

7.32 Ranbaxy
7.32.1 Company Profile
7.32.2 Product Picture and Specification
7.32.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.32.4 Ranbaxy SWOT Analysis

7.33 Reckitt Benckiser
7.33.1 Company Profile
7.33.2 Product Picture and Specification
7.33.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.33.4 Reckitt Benckiser SWOT Analysis

7.34 Skinvisible Pharmaceuticals
7.34.1 Company Profile
7.34.2 Product Picture and Specification
7.34.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.34.4 Skinvisible Pharmaceuticals SWOT Analysis

7.35 Versapharm
7.35.1 Company Profile
7.35.2 Product Picture and Specification
7.35.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.35.4 Versapharm SWOT Analysis

7.36 XBiotech
7.36.1 Company Profile
7.36.2 Product Picture and Specification
7.36.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.36.4 XBiotech SWOT Analysis

8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Acne Drugs Product Types
8.5 Market Share Analysis of Different Acne Drugs Price Levels
8.6 Gross Margin Analysis of Different Acne Drugs Applications

9 Marketing Trader or Distributor Analysis of Acne Drugs
9.1 Marketing Channels Status of Acne Drugs
9.2 Traders or Distributors of Acne Drugs with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Acne Drugs
9.4 North America Import, Export and Trade Analysis of Acne Drugs

10 Development Trend of Acne Drugs Industry 2016-2021
10.1 Capacity and Production Overview of Acne Drugs 2016-2021
10.2 Production Market Share by Product Types of Acne Drugs 2016-2021
10.3 Sales and Sales Revenue Overview of Acne Drugs 2016-2021
10.4 North America Sales of Acne Drugs by Applications 2016-2021
10.5 Import, Export and Consumption of Acne Drugs 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Acne Drugs 2016-2021

11 Industry Chain Suppliers of Acne Drugs with Contact Information
11.1 Major Raw Materials Suppliers of Acne Drugs with Contact Information
11.2 Manufacturing Equipment Suppliers of Acne Drugs with Contact Information
11.3 Major Players of Acne Drugs with Contact Information
11.4 Key Consumers of Acne Drugs with Contact Information
11.5 Supply Chain Relationship Analysis of Acne Drugs

12 New Project Investment Feasibility Analysis of Acne Drugs
12.1 New Project SWOT Analysis of Acne Drugs
12.2 New Project Investment Feasibility Analysis of Acne Drugs

13 Conclusion of the North America Acne Drugs Industry 2016 Market Research Report




List of Tables and Figures

Figure Picture of Acne Drugs
Table Product Specifications of Acne Drugs
Table Classification of Acne Drugs
Figure North America Sales Market Share of Acne Drugs by Product Types in 2015
Table Applications of Acne Drugs
Figure North America Sales Market Share of Acne Drugs by Applications in 2015
Figure Industry Chain Structure of Acne Drugs
Table North America Industry Overview of Acne Drugs
Table Industry Policy of Acne Drugs
Table Industry News List of Acne Drugs
Table Bill of Materials (BOM) of Acne Drugs
Table Bill of Materials (BOM) Price of Acne Drugs
Table Labor Cost of Acne Drugs
Table Depreciation Cost of Acne Drugs
Table Manufacturing Cost Structure Analysis of Acne Drugs in 2015
Figure Manufacturing Process Analysis of Acne Drugs
Table North America Price Analysis of Acne Drugs 2011-2016 (USD/Dose)
Table North America Cost Analysis of Acne Drugs 2011-2016 (USD/Dose)
Table North America Gross Analysis of Acne Drugs 2011-2016
Table Capacity (K Doses) and Commercial Production Date of North America Acne Drugs Key Manufacturers in 2015
Table Manufacturing Plants Distribution of North America Key Acne Drugs Manufacturers in 2015
Table RandD Status and Technology Source of North America Acne Drugs Key Manufacturers in 2015
Table Raw Materials Sources Analysis of North America and North America Acne Drugs Key Manufacturers in 2015
Table North America Production of Acne Drugs by Regions 2011-2016 (K Doses)
Table North America Production Market Share of Acne Drugs by Regions 2011-2016
Figure North America Production Market Share of Acne Drugs by Regions in 2014
Figure North America Production Market Share of Acne Drugs by Regions in 2015
Table North America Production of Acne Drugs by Types in 2011-2016 (K Doses)
Table North America Production Market Share of Acne Drugs by Type in 2011-2016
Figure North America Production Market Share of Acne Drugs by Type in 2014
Figure North America Production Market Share of Acne Drugs by Type in 2015
Table North America Sales of Acne Drugs by Applications 2011-2016 (K Doses)
Table North America Production Market Share of Acne Drugs by Applications 2011-2016
Figure North America Production Market Share of Acne Drugs by Applications in 2014
Figure North America Production Market Share of Acne Drugs by Applications in 2015
Table Price Comparison of North America Acne Drugs Key Manufacturers in 2015 (USD/Dose)
Table North America Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Acne Drugs 2011-2016
Table North America Consumption Volume of Acne Drugs by Regions 2011-2016 (K Doses)
Table North America Consumption Volume Market Share of Acne Drugs by Regions 2011-2016
Figure North America Consumption Volume Market Share of Acne Drugs by Regions in 2014
Figure North America Consumption Volume Market Share of Acne Drugs by Regions in 2015
Table North America Consumption Value of Acne Drugs by Regions 2011-2016 (M USD)
Table North America Consumption Value Market Share of Acne Drugs by Regions 2011-2016
Figure North America Consumption Value Market Share of Acne Drugs by Regions in 2014
Figure North America Consumption Value Market Share of Acne Drugs by Regions in 2015
Table Consumption Price of Acne Drugs by Regions 2011-2016 (USD/Dose)
Table North America and Major Manufacturers Capacity of Acne Drugs 2011-2016 (K Doses)
Table North America Capacity Market Share of Major Acne Drugs Manufacturers 2011-2016
Table North America and Major Manufacturers Production of Acne Drugs 2011-2016 (K Doses)
Table North America Production Market Share of Major Acne Drugs Manufacturers 2011-2016
Table North America and Major Manufacturers Sales of Acne Drugs 2011-2016 (K Doses)
Table North America Sales Market Share of Major Acne Drugs Manufacturers 2011-2016
Table North America and Major Manufacturers Sales Revenue of Acne Drugs 2011-2016 (M USD)
Table North America Sales Revenue Market Share of Major Acne Drugs Manufacturers 2011-2016
Figure North America Capacity (K Doses), Production (K Doses) and Growth Rate of Acne Drugs 2011-2016
Figure North America Capacity Utilization Rate of Acne Drugs 2011-2016
Figure North America Sales Revenue (M USD) and Growth Rate of Acne Drugs 2011-2016
Figure North America Production Market Share of Major Acne Drugs Manufacturers in 2014
Figure North America Production Market Share of Major Acne Drugs Manufacturers in 2015
Figure North America Sales Market Share of Major Acne Drugs Manufacturers in 2014
Figure North America Sales Market Share of Major Acne Drugs Manufacturers in 2015
Figure North America Sales (K Doses) and Growth Rate of Acne Drugs 2011-2016
Table North America Supply, Consumption and Gap of Acne Drugs 2011-2016 (K Doses)
Table North America Import, Export and Consumption of Acne Drugs 2011-2016 (K Doses)
Table Price of North America Acne Drugs Major Manufacturers 2011-2016 (USD/Dose)
Table Gross Margin of North America Acne Drugs Major Manufacturers 2011-2016
Table North America and Major Manufacturers Revenue of Acne Drugs 2011-2016 (M USD)
Table North America Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Acne Drugs 2011-2016
Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Pfizer
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Pfizer 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Pfizer 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Pfizer 2011-2016
Table Pfizer Acne Drugs SWOT Analysis
Table Galderma Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Galderma
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Galderma 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Galderma 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Galderma 2011-2016
Table Galderma Acne Drugs SWOT Analysis
Table Stiefel Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Stiefel
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Stiefel 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Stiefel 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Stiefel 2011-2016
Table Stiefel Acne Drugs SWOT Analysis
Table Valeant Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Valeant
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Valeant 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Valeant 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Valeant 2011-2016
Table Valeant Acne Drugs SWOT Analysis
Table Bayer HealthCare Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Bayer HealthCare
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bayer HealthCare 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Bayer HealthCare 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Bayer HealthCare 2011-2016
Table Bayer HealthCare Acne Drugs SWOT Analysis
Table AndroScience Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of AndroScience
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of AndroScience 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of AndroScience 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of AndroScience 2011-2016
Table AndroScience Acne Drugs SWOT Analysis
Table GlaxoSmithKline Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of GlaxoSmithKline
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of GlaxoSmithKline 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of GlaxoSmithKline 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of GlaxoSmithKline 2011-2016
Table GlaxoSmithKline Acne Drugs SWOT Analysis
Table Johnson and Johnson Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Johnson and Johnson
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Johnson and Johnson 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Johnson and Johnson 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Johnson and Johnson 2011-2016
Table Johnson and Johnson Acne Drugs SWOT Analysis
Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Roche
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Roche 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Roche 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Roche 2011-2016
Table Roche Acne Drugs SWOT Analysis
Table Foamix Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Foamix
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Foamix 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Foamix 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Foamix 2011-2016
Table Foamix Acne Drugs SWOT Analysis
Table Promius Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Promius Pharma
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Promius Pharma 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Promius Pharma 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Promius Pharma 2011-2016
Table Promius Pharma Acne Drugs SWOT Analysis
Table Teva Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Teva
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Teva 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Teva 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Teva 2011-2016
Table Teva Acne Drugs SWOT Analysis
Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Roche
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Roche 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Roche 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Roche 2011-2016
Table Roche Acne Drugs SWOT Analysis
Table Anterios Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Anterios
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Anterios 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Anterios 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Anterios 2011-2016
Table Anterios Acne Drugs SWOT Analysis
Table Aqua Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Aqua Pharmaceuticals
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Aqua Pharmaceuticals 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Aqua Pharmaceuticals 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Aqua Pharmaceuticals 2011-2016
Table Aqua Pharmaceuticals Acne Drugs SWOT Analysis
Table Astellas Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Astellas
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Astellas 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Astellas 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Astellas 2011-2016
Table Astellas Acne Drugs SWOT Analysis
Table BioPharmX Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of BioPharmX
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of BioPharmX 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of BioPharmX 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of BioPharmX 2011-2016
Table BioPharmX Acne Drugs SWOT Analysis
Table Celtaxsys Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Celtaxsys
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Celtaxsys 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Celtaxsys 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Celtaxsys 2011-2016
Table Celtaxsys Acne Drugs SWOT Analysis
Table Cipher Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Cipher Pharmaceuticals
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Cipher Pharmaceuticals 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Cipher Pharmaceuticals 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Cipher Pharmaceuticals 2011-2016
Table Cipher Pharmaceuticals Acne Drugs SWOT Analysis
Table COSMO Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of COSMO Pharmaceuticals
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of COSMO Pharmaceuticals 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of COSMO Pharmaceuticals 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of COSMO Pharmaceuticals 2011-2016
Table COSMO Pharmaceuticals Acne Drugs SWOT Analysis
Table Dermira Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Dermira
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dermira 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Dermira 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Dermira 2011-2016
Table Dermira Acne Drugs SWOT Analysis
Table Elorac Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Elorac
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Elorac 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Elorac 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Elorac 2011-2016
Table Elorac Acne Drugs SWOT Analysis
Table Guthy-Renker Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Guthy-Renker
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Guthy-Renker 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Guthy-Renker 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Guthy-Renker 2011-2016
Table Guthy-Renker Acne Drugs SWOT Analysis
Table Helix BioMedix Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Helix BioMedix
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Helix BioMedix 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Helix BioMedix 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Helix BioMedix 2011-2016
Table Helix BioMedix Acne Drugs SWOT Analysis
Table Hygeia Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Hygeia Therapeutics
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Hygeia Therapeutics 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Hygeia Therapeutics 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Hygeia Therapeutics 2011-2016
Table Hygeia Therapeutics Acne Drugs SWOT Analysis
Table Meda Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Meda
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Meda 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Meda 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Meda 2011-2016
Table Meda Acne Drugs SWOT Analysis
Table Mylan Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Mylan
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Mylan 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Mylan 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Mylan 2011-2016
Table Mylan Acne Drugs SWOT Analysis
Table Novan Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Novan
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Novan 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Novan 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Novan 2011-2016
Table Novan Acne Drugs SWOT Analysis
Table Oculus Innovative Sciences Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Oculus Innovative Sciences
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Oculus Innovative Sciences 2011-2016
Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Oculus Innovative Sciences 2011-2016
Figure Acne Drugs Production (K Doses) and North America Market Share of Oculus Innovative Sciences 2011-2016
Table Oculus Innovative Sciences Acne Drugs SWOT Analysis
Table Paratek Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Acne Drugs Picture and Specifications of Paratek Pharmaceuticals
Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Paratek Pharmaceuticals 2011-2016
Figure Acne Dr

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Zinc Bacitracin Market Research Report 2016

Global Zinc Bacitracin Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Zinc Bacitracin Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Zinc Bacitracin industry, focusing on the main regions ...

2016 Tolnaftate (CAS 2398-96-1) Industry Market Report

2016 Tolnaftate (CAS 2398-96-1) Industry Market Report

  • $ 2800
  • Industry report
  • August 2016
  • by Prof Research

The 'Global and Chinese Tolnaftate Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Tolnaftate industry with a focus on the Chinese market. ...

2016 Global and Chinese Povidone-Iodine (CAS 25655-41-8) Industry Market Research Report

2016 Global and Chinese Povidone-Iodine (CAS 25655-41-8) Industry Market Research Report

  • $ 2800
  • Industry report
  • September 2016
  • by Prof Research

The 'Global and Chinese Povidone-Iodine Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Povidone-Iodine industry with a focus on the ...


Download Unlimited Documents from Trusted Public Sources

Acne Treatment Industry in the US

  • October 2016
    7 pages
  • Acne Treatment  

  • United States  

    Chile  

    World  

View report >

Acne Treatment Industry in Europe

  • September 2016
    12 pages
  • Acne Treatment  

    Milk  

  • Europe  

View report >

Acne Treatment Industry in South Africa

  • August 2016
    126 pages
  • Acne Treatment  

    Food  

    Endocrine Disea...  

  • South Africa  

    Africa  

View report >

Otc Markets In The Us

8 months ago

Related Market Segments :

Acne Treatment

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.